Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 13, 2023 17:00 ET | Source: Anika Therapeutics Inc.

Anika Enters Into Cooperation Agreement with Caligan Partners

Gary Fischetti Joins Anika Board Announces Share Repurchase Program Forms Capital Allocation Committee BEDFORD, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK)...
April 12, 2023 09:00 ET | Source: Anika Therapeutics Inc.

Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference

BEDFORD, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...
April 03, 2023 09:00 ET | Source: Anika Therapeutics Inc.

Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA

Tactoset cleared by the FDA to be combined with autologous bone marrow aspirate, a core element for regenerative healing Anika reaches agreement to distribute the Marrow Cellution™ Bone Marrow...
March 27, 2023 08:55 ET | Source: Anika Therapeutics Inc.

Anika Files Preliminary Proxy Statement

BEDFORD, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK) (“Anika” or the “Company”), a global joint preservation company in early intervention orthopedics, today...
March 15, 2023 16:01 ET | Source: Anika Therapeutics Inc.

Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

BEDFORD, Mass., March 15, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...
March 08, 2023 10:00 ET | Source: Anika Therapeutics Inc.

Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting

Recently Commenced Full Market Release of X-Twist™ Fixation System, a Cornerstone Product in Anika’s Sports Medicine Portfolio RevoMotion™ Reverse Shoulder Arthroplasty System Now in Limited Market...
March 06, 2023 16:05 ET | Source: Anika Therapeutics Inc.

Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results

Delivered Fourth Quarter Revenue Growth of 11% and Full Year 2022 Revenue Growth of 6% Completed First Surgeries and Initiated Limited Market Release of New RevoMotion™ Reverse Shoulder Arthroplasty...
February 28, 2023 09:00 ET | Source: Anika Therapeutics Inc.

Anika to Participate in the Canaccord Genuity Musculoskeletal Conference

BEDFORD, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
February 21, 2023 10:30 ET | Source: Anika Therapeutics Inc.

Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023

BEDFORD, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
February 21, 2023 10:00 ET | Source: Anika Therapeutics Inc.

Anika Issues Statement

BEDFORD, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today issued the following statement...